A

ANABV

AnaptysBio, Inc. Common Stock When Issued

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$46.87

Market Cap

$1.35B

Beta

0.41

P/E

—

Div Yield

—

Sector Median P/E

—

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+0.00%

Revenue CAGR 3Y+0.00%

P/E Ratio—

PEG Ratio—

FCF Yield+0.00%

Debt / Equity—

Interest Coverage—

Sign up free to unlock full analysis

✓Full 24-factor quality scorecard
✓AI investment committee analysis
✓Factor radar & value trap detection
✓10-year strategy backtesting
✓Advanced screening & filtering

Get started free

No credit card required

Want weekly signals for ANABV? Get them free →

Already have an account? Sign in

ANABV Stock Analysis — AnaptysBio, Inc. Common Stock When Issued Quality Score, P/E, Signal | Tessera Alpha